Literature DB >> 17306742

Clinical tolerance following liver transplantation: long term results and future prospects.

George V Mazariegos1, Rakesh Sindhi, Angus W Thomson, Amadeo Marcos.   

Abstract

The ongoing quest of achieving clinical transplantation tolerance has been fueled, in large part, by the success of solid organ transplantation. Long term morbidity following transplantation now is primarily related to complications of immunosuppression (IS) such as malignancy, drug toxicity, or infection. This report provides long term follow-up on a large cohort of operationally tolerant patients, provides clinical guidelines to be considered in IS withdrawal, and identifies future prospects for achieving consistent clinical tolerance following liver transplantation (LT).

Entities:  

Mesh:

Year:  2006        PMID: 17306742     DOI: 10.1016/j.trim.2006.09.033

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  15 in total

Review 1.  Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.

Authors:  Alberto Sánchez-Fueyo; Terry B Strom
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

Review 2.  Clinical transplantation tolerance.

Authors:  Kenneth A Newell
Journal:  Semin Immunopathol       Date:  2011-02-14       Impact factor: 9.623

Review 3.  Current developments in pediatric liver transplantation.

Authors:  Christina Hackl; Hans J Schlitt; Michael Melter; Birgit Knoppke; Martin Loss
Journal:  World J Hepatol       Date:  2015-06-18

4.  Posttransplant metabolic syndrome in the withdrawal of immunosuppression in Pediatric Liver Transplant Recipients (WISP-R) pilot trial.

Authors:  E R Perito; S Mohammad; P Rosenthal; E M Alonso; U D Ekong; S J Lobritto; S Feng
Journal:  Am J Transplant       Date:  2015-02-03       Impact factor: 8.086

Review 5.  The SPLIT research agenda 2013.

Authors:  Estella M Alonso; Vicky L Ng; Ravinder Anand; Christopher D Anderson; Udeme D Ekong; Emily M Fredericks; Katryn N Furuya; Nitika A Gupta; Stacee M Lerret; Shikha Sundaram; Greg Tiao
Journal:  Pediatr Transplant       Date:  2013-05-30

6.  Expression of alpha smooth muscle actin in living donor liver transplant recipients.

Authors:  Masataka Hirabaru; Kyoko Mochizuki; Mitsuhisa Takatsuki; Akihiko Soyama; Taiichiro Kosaka; Tamotsu Kuroki; Isao Shimokawa; Susumu Eguchi
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

7.  Risk factors for rejection and infection in pediatric liver transplantation.

Authors:  R W Shepherd; Y Turmelle; M Nadler; J A Lowell; M R Narkewicz; S V McDiarmid; R Anand; C Song
Journal:  Am J Transplant       Date:  2007-12-19       Impact factor: 8.086

8.  BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION.

Authors:  Sebastiaan Heidt; Kathryn J Wood
Journal:  Expert Opin Med Diagn       Date:  2012-07

9.  NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation.

Authors:  Antonino Castellaneta; Tina L Sumpter; Lieping Chen; Daisuke Tokita; Angus W Thomson
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

Review 10.  Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?

Authors:  Sandy Feng
Journal:  Curr Opin Organ Transplant       Date:  2008-10       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.